Search

Edward A. Miller

Examiner (ID: 14808)

Most Active Art Unit
2204
Art Unit(s)
2899, 2605, 2203, 1801, 3641, 2200, 2204, 1802
Total Applications
1187
Issued Applications
889
Pending Applications
53
Abandoned Applications
244

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5290478 [patent_doc_number] => 20090023208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Cultivation of Primate Embryonic Cells' [patent_app_type] => utility [patent_app_number] => 12/240640 [patent_app_country] => US [patent_app_date] => 2008-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5757 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023208.pdf [firstpage_image] =>[orig_patent_app_number] => 12240640 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/240640
Cultivation of Primate Embryonic Cells Sep 28, 2008 Abandoned
Array ( [id] => 5485363 [patent_doc_number] => 20090275128 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'MEDIUM AND CULTURE OF EMBRYONIC STEM CELLS' [patent_app_type] => utility [patent_app_number] => 12/209325 [patent_app_country] => US [patent_app_date] => 2008-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3975 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275128.pdf [firstpage_image] =>[orig_patent_app_number] => 12209325 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/209325
MEDIUM AND CULTURE OF EMBRYONIC STEM CELLS Sep 11, 2008 Abandoned
Array ( [id] => 5954505 [patent_doc_number] => 20110034540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'Use of the CYP46A1 Gene for the Treatment of Alzheimer\'s Disease' [patent_app_type] => utility [patent_app_number] => 12/678020 [patent_app_country] => US [patent_app_date] => 2008-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10653 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20110034540.pdf [firstpage_image] =>[orig_patent_app_number] => 12678020 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/678020
CYP46A1 gene for the treatment of alzheimer's disease Sep 10, 2008 Issued
Array ( [id] => 5504466 [patent_doc_number] => 20090165154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'Transgenic ungulates having reduced prion protein activity and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/231873 [patent_app_country] => US [patent_app_date] => 2008-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 75 [patent_figures_cnt] => 75 [patent_no_of_words] => 70632 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20090165154.pdf [firstpage_image] =>[orig_patent_app_number] => 12231873 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/231873
Transgenic bovine having reduced prion protein activity and uses thereof Sep 4, 2008 Issued
Array ( [id] => 5423186 [patent_doc_number] => 20090149642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'ENRICHED PREPARATION OF HUMAN FETAL MULTIPOTENTIAL NEURAL STEM CELLS' [patent_app_type] => utility [patent_app_number] => 12/202879 [patent_app_country] => US [patent_app_date] => 2008-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 10954 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20090149642.pdf [firstpage_image] =>[orig_patent_app_number] => 12202879 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/202879
ENRICHED PREPARATION OF HUMAN FETAL MULTIPOTENTIAL NEURAL STEM CELLS Sep 1, 2008 Abandoned
Array ( [id] => 5539687 [patent_doc_number] => 20090221492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'EXPRESSION OF ACTIVE HUMAN FACTOR IX IN MAMMARY TISSUE OF TRANSGENIC ANIMALS' [patent_app_type] => utility [patent_app_number] => 12/201673 [patent_app_country] => US [patent_app_date] => 2008-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13116 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221492.pdf [firstpage_image] =>[orig_patent_app_number] => 12201673 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/201673
EXPRESSION OF ACTIVE HUMAN FACTOR IX IN MAMMARY TISSUE OF TRANSGENIC ANIMALS Aug 28, 2008 Abandoned
Array ( [id] => 6614895 [patent_doc_number] => 20100310525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'WNT PATHWAY STIMULATION IN REPROGRAMMING SOMATIC CELLS' [patent_app_type] => utility [patent_app_number] => 12/675681 [patent_app_country] => US [patent_app_date] => 2008-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 31771 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0310/20100310525.pdf [firstpage_image] =>[orig_patent_app_number] => 12675681 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/675681
WNT pathway stimulation in reprogramming somatic cells with nuclear reprogramming factors Aug 28, 2008 Issued
Array ( [id] => 53245 [patent_doc_number] => 07772204 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-08-10 [patent_title] => 'Perlecan and growth factor for wound and cutaneous injury healing' [patent_app_type] => utility [patent_app_number] => 12/196992 [patent_app_country] => US [patent_app_date] => 2008-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9823 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/772/07772204.pdf [firstpage_image] =>[orig_patent_app_number] => 12196992 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/196992
Perlecan and growth factor for wound and cutaneous injury healing Aug 21, 2008 Issued
Array ( [id] => 5473047 [patent_doc_number] => 20090246213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'VACCINE COMPRISING A POLYNUCLEOTIDE ENCODING AN ANTIGEN RECOGNIZED BY A CD4+ HELPER T-CELL AND A POLYNUCLEOTIDE ENCODING A TUMOR SPECIFIC OR ASSOCIATED ANTIGEN RECOGNIZED BY A CD8+ CTL' [patent_app_type] => utility [patent_app_number] => 12/194453 [patent_app_country] => US [patent_app_date] => 2008-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9526 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20090246213.pdf [firstpage_image] =>[orig_patent_app_number] => 12194453 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/194453
VACCINE COMPRISING A POLYNUCLEOTIDE ENCODING AN ANTIGEN RECOGNIZED BY A CD4+ HELPER T-CELL AND A POLYNUCLEOTIDE ENCODING A TUMOR SPECIFIC OR ASSOCIATED ANTIGEN RECOGNIZED BY A CD8+ CTL Aug 18, 2008 Abandoned
Array ( [id] => 5580488 [patent_doc_number] => 20090175834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'NEURONAL PROGENITOR CELLS AND METHODS OF DERIVATION AND PURIFICATION OF NEURONAL PROGENITOR CELLS FROM EMBRYONIC STEM CELLS' [patent_app_type] => utility [patent_app_number] => 12/185695 [patent_app_country] => US [patent_app_date] => 2008-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13481 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20090175834.pdf [firstpage_image] =>[orig_patent_app_number] => 12185695 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/185695
Methods of derivation of neuronal progenitor cells from embryonic stem cells Aug 3, 2008 Issued
Array ( [id] => 22904 [patent_doc_number] => 07799969 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-21 [patent_title] => 'Methods for cloning rats by nuclear transfer' [patent_app_type] => utility [patent_app_number] => 12/184328 [patent_app_country] => US [patent_app_date] => 2008-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5512 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 184 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/799/07799969.pdf [firstpage_image] =>[orig_patent_app_number] => 12184328 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/184328
Methods for cloning rats by nuclear transfer Jul 31, 2008 Issued
Array ( [id] => 5360490 [patent_doc_number] => 20090035284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-05 [patent_title] => 'DERIVATION OF NEURAL STEM CELLS FROM EMBRYONIC STEM CELLS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/182050 [patent_app_country] => US [patent_app_date] => 2008-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8297 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20090035284.pdf [firstpage_image] =>[orig_patent_app_number] => 12182050 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/182050
Derivation of neural stem cells from embryonic stem cells Jul 28, 2008 Issued
Array ( [id] => 5412133 [patent_doc_number] => 20090126032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'Method to produce cloned embryos and adults from cultured cells' [patent_app_type] => utility [patent_app_number] => 12/221060 [patent_app_country] => US [patent_app_date] => 2008-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17334 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0126/20090126032.pdf [firstpage_image] =>[orig_patent_app_number] => 12221060 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/221060
Method to produce cloned embryos and adults from cultured cells Jul 28, 2008 Abandoned
Array ( [id] => 5391146 [patent_doc_number] => 20090208459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'Methods of treating anemia using recombinant adeno-associated virus virions' [patent_app_type] => utility [patent_app_number] => 12/218508 [patent_app_country] => US [patent_app_date] => 2008-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16532 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20090208459.pdf [firstpage_image] =>[orig_patent_app_number] => 12218508 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/218508
Methods of treating anemia using recombinant adeno-associated virus virions Jul 14, 2008 Issued
Array ( [id] => 4948958 [patent_doc_number] => 20080305084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions' [patent_app_type] => utility [patent_app_number] => 12/218394 [patent_app_country] => US [patent_app_date] => 2008-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15914 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20080305084.pdf [firstpage_image] =>[orig_patent_app_number] => 12218394 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/218394
Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions Jul 14, 2008 Issued
Array ( [id] => 5290423 [patent_doc_number] => 20090023153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Targeted modification of chromatin structure' [patent_app_type] => utility [patent_app_number] => 12/217953 [patent_app_country] => US [patent_app_date] => 2008-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 30077 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023153.pdf [firstpage_image] =>[orig_patent_app_number] => 12217953 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/217953
Targeted modification of chromatin structure Jul 9, 2008 Issued
Array ( [id] => 4711056 [patent_doc_number] => 20080299582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'Culture System for Rapid Expansion of Human Embryonic Stem Cells' [patent_app_type] => utility [patent_app_number] => 12/170219 [patent_app_country] => US [patent_app_date] => 2008-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15132 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20080299582.pdf [firstpage_image] =>[orig_patent_app_number] => 12170219 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/170219
Human embryonic stem cells genetically modified to contain a nucleic acid and cultured with fibroblast growth factor Jul 8, 2008 Issued
Array ( [id] => 5271016 [patent_doc_number] => 20090074792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Compositions containing full-length L1R nucleic acid and endoplasmic reticulum-targeting sequence, and methods of use' [patent_app_type] => utility [patent_app_number] => 12/217584 [patent_app_country] => US [patent_app_date] => 2008-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 19805 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20090074792.pdf [firstpage_image] =>[orig_patent_app_number] => 12217584 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/217584
DNA immunogenic composition comprising a full-length modified poxvirus L1R gene fused to a tPA leader sequence Jul 6, 2008 Issued
Array ( [id] => 6636693 [patent_doc_number] => 20100173800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'DELIVERY OF NUCLEIC ACIDS INTO GENOMES OF HUMAN STEM CELLS USING IN VITRO ASSEMBLED MU TRANSPOSITION COMPLEXES' [patent_app_type] => utility [patent_app_number] => 12/667853 [patent_app_country] => US [patent_app_date] => 2008-07-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7330 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173800.pdf [firstpage_image] =>[orig_patent_app_number] => 12667853 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/667853
DELIVERY OF NUCLEIC ACIDS INTO GENOMES OF HUMAN STEM CELLS USING IN VITRO ASSEMBLED MU TRANSPOSITION COMPLEXES Jul 3, 2008 Abandoned
Array ( [id] => 8621456 [patent_doc_number] => 08354370 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-15 [patent_title] => 'Administering a biological composition or compositions isolated from self-renewing colony forming somatic cell growth medium to treat diseases and disorders' [patent_app_type] => utility [patent_app_number] => 12/140065 [patent_app_country] => US [patent_app_date] => 2008-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 29 [patent_no_of_words] => 40148 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12140065 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/140065
Administering a biological composition or compositions isolated from self-renewing colony forming somatic cell growth medium to treat diseases and disorders Jun 15, 2008 Issued
Menu